Business
FDA approves weight-loss drug Zepbound to treat sleep apnea - The Washington Post
It marks the first medication for certain patients with the condition.
By: The Washington Post
- Dec 22 2024
- 0
- 0 Views
The Food and Drug Administration on Friday approved Eli Lillys weight-loss drug Zepbound to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, marking it the first … [+2963 chars]